Business Description
Biolidics Ltd
ISIN : SGXE89830751
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | -2.46 | |||||
Debt-to-Equity | -1 | |||||
Debt-to-EBITDA | -0.64 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -154.02 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60.7 | |||||
3-Year EBITDA Growth Rate | 32.5 | |||||
3-Year EPS without NRI Growth Rate | 38.3 | |||||
3-Year FCF Growth Rate | 35.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.09 | |||||
9-Day RSI | 45.52 | |||||
14-Day RSI | 46.95 | |||||
6-1 Month Momentum % | -26.67 | |||||
12-1 Month Momentum % | -21.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.24 | |||||
Quick Ratio | 0.24 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 360.56 | |||||
Days Sales Outstanding | 250.94 | |||||
Days Payable | 163.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.1 | |||||
Shareholder Yield % | 1.15 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.72 | |||||
Operating Margin % | -581.99 | |||||
Net Margin % | -1068.02 | |||||
FCF Margin % | -838.97 | |||||
ROA % | -118.34 | |||||
ROIC % | -55.64 | |||||
ROC (Joel Greenblatt) % | -1798.59 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.5 | |||||
EV-to-EBIT | -3.44 | |||||
EV-to-EBITDA | -3.67 | |||||
EV-to-Revenue | 35.52 | |||||
EV-to-FCF | -4.56 | |||||
Earnings Yield (Greenblatt) % | -29.11 | |||||
FCF Yield % | -27.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biolidics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil S$) | 0.272 | ||
EPS (TTM) (S$) | -0.004 | ||
Beta | 2.1 | ||
Volatility % | 32.32 | ||
14-Day RSI | 46.95 | ||
14-Day ATR (S$) | 0.00085 | ||
20-Day SMA (S$) | 0.01125 | ||
12-1 Month Momentum % | -21.43 | ||
52-Week Range (S$) | 0.01 - 0.019 | ||
Shares Outstanding (Mil) | 744.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biolidics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biolidics Ltd Stock Events
Event | Date | Price(S$) | ||
---|---|---|---|---|
No Event Data |
Biolidics Ltd Frequently Asked Questions
What is Biolidics Ltd(SGX:8YY)'s stock price today?
When is next earnings date of Biolidics Ltd(SGX:8YY)?
Does Biolidics Ltd(SGX:8YY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |